Home Healthcare Market Size, Trends, and Forecast 2030

Name: Home Healthcare Market Size, Trends, and Forecast 2030
Creator: Mordor Intelligence
License: https://www.mordorintelligence.com/privacy-policy

Global Home Healthcare Market Size and Share

Market Overview

Study Period	2019 - 2030
Market Size (2025)	USD 335.22 Billion
Market Size (2030)	USD 503.12 Billion
Growth Rate (2025 - 2030)	8.46% CAGR
Fastest Growing Market	Asia Pacific
Largest Market	North America
Market Concentration	Medium
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Home Healthcare Market Summary — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Global Home Healthcare Market Analysis by Mordor Intelligence

The Global Home Healthcare Market size is estimated at USD 335.22 billion in 2025, and is expected to reach USD 503.12 billion by 2030, at a CAGR of 8.46% during the forecast period (2025-2030).

Growth rests on three converging forces: a rapidly aging global population, broadening reimbursement for remote patient monitoring, and continuous innovation in AI-enabled connected devices that shift care from hospitals to homes. North America currently leads the home healthcare market with a45.50% revenue share, supported by long-standing value-based payment models and sophisticated care‐coordination infrastructure. Asia is accelerating the fastest, posting a projected12.45% CAGR as governments back digital health reforms and household incomes rise. Competitive intensity is mounting as large insurers vertically integrate home-care assets to manage total cost of care, while software vendors race to embed predictive analytics that transform episodic services into proactive health management.

Key Report Takeaways

By product type, services held 53.50% of the home healthcare market share in 2024, whereas software is advancing at a 9.10% CAGR through 2030.
By service type, skilled nursing accounted for 48.30% of the home healthcare market in 2024; rehabilitation therapy is forecast to expand at 9.56% CAGR to 2030.
By indication, cardiovascular diseases contributed 27.7% to the home healthcare market in 2024, while diabetes is poised to grow at 10.96% CAGR between 2025 and 2030.
By geography, North America dominated with 45.50% revenue share in 2024 and Asia is projected to record the strongest 12.45% CAGR through 2030

Global Home Healthcare Market Trends and Insights

Driver Impact Analysis

Driver	(~) % Impact on CAGR Forecast	Geographic Relevance	Peak Impact
Aging Populations Driving Chronic-Care Home Demand	~+2.1	Global, with highest impact in North America, Europe, and developed APAC	Long term (≥ 5 yrs)
Reimbursement Expansion for Remote Patient Monitoring	~+1.3	North America & EU, expanding to APAC core markets	Medium term (~ 3-4 yrs)
AI-Enabled Connected Devices Accelerating Proactive Home Care	~+1.8	Global, with early adoption in North America, spill-over to APAC and EU	Medium term (~ 3-4 yrs)
Rising Disposable Income and Increasing Cases of Surgical Procedures	~+0.9	Global, with pronounced impact in emerging APAC and Latin America	Short term (≤ 2 yrs)
Shift of Acute-Care Episodes to "Hospital-at-Home" Models	~+1.4	North America & EU core, expanding to developed APAC markets	Medium term (~ 3-4 yrs)
Venture Funding Surge into Home-Care Platforms in Emerging Markets	~+0.7	APAC core, Latin America, with spill-over to MEA	Short term (≤ 2 yrs

Source: Mordor Intelligence

Aging populations driving chronic-care home demand

More than 10,000 Americans turn 65 every day through 2030, and 91% of older adults prefer to age in place. Simultaneously, 95% of seniors manage at least one chronic illness, pushing health systems to extend complex services into domestic settings. Payers view home-based programs as critical levers to curb avoidable hospitalizations, a position reinforced by global spending on senior care. Providers are therefore building condition-specific pathways that integrate remote monitoring, predictive analytics, and multidisciplinary teams to control comorbidities and enhance quality-of-life metrics that increasingly influence reimbursements Comfort Keepers.

Reimbursement expansion for remote patient monitoring

CMS has opened permanent billing pathways for remote patient monitoring through CPT codes 99453, 99454, 99457, and 99458. Payments range from USD 22.25 for initial setup to USD 66.94 for monthly clinical oversight, creating fresh revenue streams while lowering readmission penalties ^{[1]Source: Centers for Medicare & Medicaid Services, “CY 2025 Home Health Prospective Payment System Rate Update,” cms.gov}. Private insurers are aligning policies; UnitedHealthcare’s 2025 updates formally encompass home-based vitals collection, driving provider adoption and investment in connected devices that feed data directly into electronic health records.

AI-enabled connected devices accelerating proactive home care

Forty-one percent of health-care executives plan to increase spending on remote patient monitoring in 2025. Devices such as Abbott’s Lingo biowearable deliver continuous metabolic insights, while Xandar Kardian’s radar-based XK300 passively tracks heart and respiratory rates without user action. When these data streams auto-populate EHRs—Abbott’s FreeStyle Libre integrates with Epic—clinicians receive real-time alerts that flag deterioration before symptoms appear, enabling intervention that keeps patients out of emergency rooms.

Shift of acute-care episodes to hospital-at-home models

Hospital-at-home programs routinely cut total episode costs 30–50% compared with brick-and-mortar stays, yet achieve comparable clinical outcomes. Academic medical centers piloting such models report higher patient satisfaction scores and lower infection rates. Regulatory waivers introduced during recent public-health emergencies confirmed the feasibility of delivering infusion, imaging, and acute monitoring in living rooms, a development now codified in permanent payer policies that encourage broader rollouts.

Restraint Impact Analysis

Restraint	(~) % Impact on CAGR Forecast	Geographic Relevance	Peak Impact
Lack of Awareness among the Developing and Underdeveloped Countries	~-1.2	APAC emerging, Latin America, MEA, with concentrated impact in rural areas	Long term (≥ 5 yrs)
Shortage of Skilled Home-Care Nurses	~-1.6	Global, with acute impact in North America and developed APAC markets	Medium term (~ 3-4 yrs)
Cyber-Security & Privacy Concerns Around Home IoT Medical Devices	~-0.8	Global, with heightened concerns in North America and EU due to regulatory scrutiny	Short term (≤ 2 yrs)
Reimbursement Rate Uncertainty & Cuts for Home-Health Agencies	~-1.1	North America core, with spill-over effects to developed markets adopting similar models	Medium term (~ 3-4 yrs)

Source: Mordor Intelligence

Shortage of skilled home-care nurses

Home health agencies face an average of 718,900 caregiver openings annually through 2031. Wage competition from hospitals, limited career-advancement pathways, and challenging field conditions fuel turnover. Some providers combat gaps with virtual-supervision models in which a single registered nurse supports multiple aides through smart-device video links, yet scaling remains difficult. Workforce scarcity limits the home healthcare market’s capacity to absorb rising demand and may suppress growth until targeted training programs and technology substitutes mature.

Lack of awareness in developing regions

Rural areas in emerging economies often view hospitals as the default care setting, leaving sophisticated home-care services under-utilized. Cultural norms, limited broadband, and scarce professional caregivers slow diffusion, even as chronic disease burdens climb. Governments and non-profits have begun community education campaigns and are piloting mobile clinics that demonstrate tele-homecare’s effectiveness, but sustained behavior change is likely to require multi-year engagement

Segment Analysis

By Product Type: Services remain dominant while software scales quickly

Services captured 53.50% of the home healthcare market in 2024 because hands-on nursing and personal assistance are indispensable for frail seniors and post-surgical patients. Software, however, is the fastest-growing element, advancing at 9.10% CAGR as agencies digitize scheduling, billing, and clinical documentation. Suppliers such as CareVoyant centralize patient records, automate payroll, and embed artificial-intelligence decision support that allocates staff based on acuity. Integrated platforms eliminate duplicate data entry and facilitate interoperability with hospital systems, fostering operational resilience despite widespread labor shortages.

Second-generation software integrates directly with diagnostic peripherals. Abbott’s FreeStyle Libre generates glucose trends that flow to clinician dashboards, while Analog Devices’ Sensinel system transmits nine cardiopulmonary indicators that trigger early interventions. Hardware-software convergence unlocks subscription revenue models that smooth cash flow and incentivize continuous product improvements. Agencies deploying these tools report shorter visit durations and higher patient-satisfaction scores, reinforcing the competitive case for digital adoption in the home healthcare market.

By Indication: Diabetes drives technological innovation

Cardiovascular disorders accounted for 27.7% of the home healthcare market in 2024, mirroring their global prevalence and the intensive monitoring they require. Diabetes, however, exhibits the fastest 10.96% CAGR because glucose-sensing wearables and automated insulin systems reduce the labor burden of managing the disease at home. The Abbott–Medtronic integration leverages continuous glucose data to fine-tune insulin delivery for over 11 million patients who need intensive therapy.

Respiratory diseases also benefit from innovation. Miniaturized ventilators and nebulizers equipped with cellular connectivity stream usage data to cloud dashboards, enabling clinicians to adjust settings without an in-person visit. Chronic wound management gains from sensor-laden smart bandages that detect infection biomarkers ahead of symptom onset, allowing earlier antimicrobial escalation. Together these advances elevate the clinical scope of what can be safely handled outside hospitals, broadening the reachable patient base for the home healthcare market.

Geography Analysis

North America generated the largest revenue in 2024, retaining a 45.50% slice of the home healthcare market. Medicare’s Patient-Driven Groupings Model rewards agencies that prevent rehospitalizations, spurring investments in predictive analytics and integrated care coordination. CMS finalized a 0.5% payment uptick for 2025 even after applying a permanent −1.975% adjustment for budget neutrality, signaling continued regulatory support in exchange for higher outcome accountability. Private insurers mirror this stance, channeling complex chronic-care episodes into accredited home-health programs to offset inpatient costs .

Asia will deliver the highest growth at 12.45% CAGR through 2030, propelled by demographic tides and national digital-health campaigns. Nearly 40% of citizens over 60 lack pension coverage, making cost-efficient home services attractive to payers and families alike. Reforms such as India’s Ayushman Bharat Digital Mission promote electronic medical records that simplify data exchange between hospitals and home-care teams. Japan faces an extreme worker-to-retiree ratio of 2.4 by 2025, so insurers and technology firms co-develop AI-supported monitoring that reduces touch points without compromising safety.

Europe maintains steady expansion amid aging societies that prioritize aging in place. Germany subsidizes telecare devices for heart-failure patients, and the United Kingdom’s Integrated Care Boards are bundling at-home rehabilitation into their payment envelopes. Latin America and the Middle East & Africa remain the smallest segments, yet rising urbanization and private-insurance penetration create white-space opportunities. Telehealth networks are bridging urban-rural divides, and multinational providers are partnering with local clinics to pilot hybrid in-person and virtual programs that seed future scale for the home healthcare market.

Competitive Landscape

Market consolidation is accelerating as payers, hospital systems, and technology vendors pursue vertical integration. UnitedHealth Group absorbed Amedisys and LHC Group to weave home-care capacity into its Optum data platform, enabling closed-loop managed-care pathways that address social determinants and clinical needs within one ecosystem. The top five companies now command about 35% of the home healthcare market, reflecting moderate concentration.

Technology investment is the primary differentiator. Philips spent EUR 1.7 billion on R&D in 2024 and filed 594 medical-technology patents, many centered on cloud-connected biosensors and AI algorithms that triage patient data before human review Philips ^{[2]Source: Philips NV, “2024 Annual Report Highlights,” philips.com}. Start-ups such as DispatchHealth merged with Medically Home to scale on-demand acute-care visits, combining logistics software with physician staffing to enable hospital-level treatments in living rooms. Smaller regional agencies increasingly focus on niche expertise—such as pediatric complex care or advanced wound therapy—to avoid direct confrontation with multi-state giants while still capturing profitable slices of the home healthcare market.

Strategic partnerships dominate product innovation. Abbott’s alignment with Epic embeds glucose trends into clinician workflows without additional log-ins, a move likely to spur similar integrations across other chronic conditions. CoachCare’s purchase of VitalTech consolidated remote-monitoring features into one platform, broadening appeal to agencies seeking single-vendor solutions. Continuing M&A signals that capabilities breadth and data interoperability are becoming table stakes for leadership in the home healthcare market.

Global Home Healthcare Industry Leaders

Fresenius SE & Co KGaA
F. Hoffmann-La Roche AG
Apple Inc
Resmed Inc
Amwell
*Disclaimer: Major Players sorted in no particular order

Home Healthcare Market _ CL _ New.png — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Need More Details on Market Players and Competitors?

Download PDF

Recent Industry Developments

April 2025: Abbott integrated FreeStyle Libre glucose data into Epic electronic health records, giving 575,000 U.S. clinicians real-time access to home-generated metrics.
April 2025: Abbott completed the first-in-human study of its AVEIR Conduction System Pacing leadless pacemaker, targeting the left bundle branch for more physiologic pacing.
March 2025: DispatchHealth and Medically Home merged, creating the largest advanced at-home acute-care provider in the United States.
March 2025: CoachCare acquired VitalTech, adding end-to-end virtual-care and RPM capabilities to its platform.

Table of Contents for Global Home Healthcare Industry Report

1. Introduction

1.1 Study Assumptions & Market Definition
1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

4.1 Market Overview
4.2 Market Drivers
- 4.2.1 Aging Populations Driving Chronic-Care Home Demand
- 4.2.2 Reimbursement Expansion for Remote Patient Monitoring
- 4.2.3 AI-Enabled Connected Devices Accelerating Proactive Home Care
- 4.2.4 Rising Disposable Income and Increasing Cases of Surgical Procedures
- 4.2.5 Shift of Acute-Care Episodes to “Hospital-at-Home” Models
- 4.2.6 Venture Funding Surge into Home-Care Platforms in Emerging Markets
4.3 Market Restraints
- 4.3.1 Lack of Awareness among the Developing and Underdeveloped Countries
- 4.3.2 Shortage of Skilled Home-Care Nurses
- 4.3.3 Cyber-Security & Privacy Concerns Around Home IoT Medical Devices
- 4.3.4 Reimbursement Rate Uncertainty & Cuts for Home-Health Agencies
4.4 Supply-Chain Analysis
4.5 Regulatory Outlook
4.6 Technological Outlook
4.7 Porter’s Five Forces
- 4.7.1 Bargaining Power of Buyers
- 4.7.2 Bargaining Power of Suppliers
- 4.7.3 Threat of New Entrants
- 4.7.4 Threat of Substitutes
- 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value)

5.1 By Product Type
- 5.1.1 Product
- 5.1.1.1 Therapeutic Equipment
- 5.1.1.1.1 Insulin Delivery Devices
- 5.1.1.1.2 Home IV Equipment
- 5.1.1.1.3 Home Dialysis Equipment
- 5.1.1.1.4 Home Ventilators & Nebulizers
- 5.1.1.1.5 CPAP & BiPAP Devices
- 5.1.1.2 Diagnostic & Monitoring Devices
- 5.1.1.2.1 Blood Glucose Monitors
- 5.1.1.2.2 Blood Pressure Monitors
- 5.1.1.2.3 Pulse Oximeters
- 5.1.1.2.4 Holter & ECG Monitors
- 5.1.1.2.5 Digital Thermometers
- 5.1.1.3 Mobility Assist Devices
- 5.1.1.3.1 Wheelchairs
- 5.1.1.3.2 Walkers & Rollators
- 5.1.1.3.3 Mobility Scooters
- 5.1.2 Service Type
- 5.1.2.1 Skilled Nursing Services
- 5.1.2.2 Physical Therapy
- 5.1.2.3 Occupational Therapy
- 5.1.2.4 Speech Therapy
- 5.1.2.5 Hospice & Palliative Care
- 5.1.2.6 Unskilled Personal Care
- 5.1.2.7 Respiratory Therapy Services
- 5.1.2.8 Telehealth & Tele-Homecare Services
- 5.1.3 Software
- 5.1.3.1 Agency Management Software
- 5.1.3.2 Clinical Management & EHR Software
- 5.1.3.3 Remote Patient Monitoring Platforms
5.2 By Indication
- 5.2.1 Cardiovascular Diseases
- 5.2.2 Diabetes
- 5.2.3 Respiratory Diseases
- 5.2.4 Cancer
- 5.2.5 Wound Care
- 5.2.6 Neurological Disorders
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 South Korea
- 5.3.3.5 Australia
- 5.3.3.6 Rest of Asia
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America

6. Competitive Landscape

6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
- 6.4.1 Koninklijke Philips N.V.
- 6.4.2 GE HealthCare Technologies Inc.
- 6.4.3 Fresenius Medical Care AG & Co. KGaA
- 6.4.4 Amedisys Inc.
- 6.4.5 LHC Group, Inc.
- 6.4.6 Bayada Home Health Care
- 6.4.7 Kindred at Home (Humana Inc.)
- 6.4.8 ResMed Inc.
- 6.4.9 Omron Healthcare Co., Ltd.
- 6.4.10 Abbott Laboratories
- 6.4.11 Cardinal Health, Inc.
- 6.4.12 McKesson Corporation
- 6.4.13 Medtronic plc
- 6.4.14 Linde plc
- 6.4.15 Invacare Corporation
- 6.4.16 Coloplast A/S
- 6.4.17 Drive DeVilbiss Healthcare
- 6.4.18 Sunrise Medical LLC
- 6.4.19 Beijing Jiuzhou Tongbang
- 6.4.20 Home Instead, Inc.

7. Market Opportunities & Future Outlook

You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections

Get Price Break-up Now

Global Home Healthcare Market Report Scope

As per the report's scope, home health care (HHC) is intended to deliver various health services and equipment to patients at home. The HHC services are helpful when an individual requires a prolonged stay in healthcare facilities. These HHC services include various equipment, therapies, diagnosis, and software to help physicians plan efficient treatment procedures in home-care settings.

The home healthcare market is segmented by product and services, and geography. By product and services, the market is segmented as equipment, software, and services. By geography, the market is segmented as North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.

By Product Type	Product	Therapeutic Equipment	Insulin Delivery Devices
			Home IV Equipment
			Home Dialysis Equipment
			Home Ventilators & Nebulizers
			CPAP & BiPAP Devices

		Diagnostic & Monitoring Devices	Blood Glucose Monitors
			Blood Pressure Monitors
			Pulse Oximeters
			Holter & ECG Monitors
			Digital Thermometers

		Mobility Assist Devices	Wheelchairs
			Walkers & Rollators
			Mobility Scooters

	Service Type	Skilled Nursing Services
		Physical Therapy
		Occupational Therapy
		Speech Therapy
		Hospice & Palliative Care
		Unskilled Personal Care
		Respiratory Therapy Services
		Telehealth & Tele-Homecare Services

	Software	Agency Management Software
		Clinical Management & EHR Software
		Remote Patient Monitoring Platforms
By Indication	Cardiovascular Diseases
	Diabetes
	Respiratory Diseases
	Cancer
	Wound Care
	Neurological Disorders

Geography	North America	United States
		Canada
		Mexico

	Europe	Germany
		United Kingdom
		France
		Italy
		Spain
		Rest of Europe

	Asia-Pacific	China
		Japan
		India
		South Korea
		Australia
		Rest of Asia

	Middle East and Africa	GCC
		South Africa
		Rest of Middle East and Africa

	South America	Brazil
		Argentina
		Rest of South America

By Product Type

Product	Therapeutic Equipment	Insulin Delivery Devices
		Home IV Equipment
		Home Dialysis Equipment
		Home Ventilators & Nebulizers
		CPAP & BiPAP Devices

	Diagnostic & Monitoring Devices	Blood Glucose Monitors
		Blood Pressure Monitors
		Pulse Oximeters
		Holter & ECG Monitors
		Digital Thermometers

	Mobility Assist Devices	Wheelchairs
		Walkers & Rollators
		Mobility Scooters
Service Type	Skilled Nursing Services
	Physical Therapy
	Occupational Therapy
	Speech Therapy
	Hospice & Palliative Care
	Unskilled Personal Care
	Respiratory Therapy Services
	Telehealth & Tele-Homecare Services
Software	Agency Management Software
	Clinical Management & EHR Software
	Remote Patient Monitoring Platforms

By Indication

Cardiovascular Diseases

Diabetes

Respiratory Diseases

Cancer

Wound Care

Neurological Disorders

Geography

North America	United States
	Canada
	Mexico
Europe	Germany
	United Kingdom
	France
	Italy
	Spain
	Rest of Europe
Asia-Pacific	China
	Japan
	India
	South Korea
	Australia
	Rest of Asia
Middle East and Africa	GCC
	South Africa
	Rest of Middle East and Africa
South America	Brazil
	Argentina
	Rest of South America

Need A Different Region or Segment?

Customize Now

Key Questions Answered in the Report

What is the current size of the home healthcare market?

The home healthcare market size is USD 335.22 billion in 2025 and is projected to reach USD 503.12 billion by 2030.

Which region is growing fastest in home-based care?

Asia is forecast to record a 12.45% CAGR through 2030, outpacing every other region due to rapid demographic aging and supportive digital-health reforms.

How are AI-enabled devices changing home healthcare delivery?

Connected devices such as continuous glucose monitors and radar-based vital-sign sensors feed real-time data to clinicians, enabling proactive interventions that reduce emergency visits and readmissions.

What service type is expanding most quickly?

Rehabilitation therapy is the fastest-growing service area, advancing at 9.56% CAGR as payers reward functional recovery and tele-rehab technology increases therapist reach.

Why are large insurers acquiring home-health agencies?

Vertical integration allows payers to manage all points of care, control total episode costs, and capture data that improves risk adjustment and member satisfaction.

What are the main restraints on market growth?

A global shortage of skilled home-care nurses and limited awareness in developing regions collectively subtract about 2.8 percentage points from forecast CAGR by constraining service capacity and adoption.